Article Link: Genentech Announces FDA Approval for Venclexta Plus Rituxan for People With Previously Treated Chronic Lymphocytic Leukemia ...
FDA Approves Genentech’s Rituxan (rituximab) for Pemphigus Vulgaris
Article Link: FDA Approves Genentech’s Rituxan (rituximab) for Pemphigus Vulgaris South San Francisco, CA — June 7, 2018 — Ge...
FDA Approves Mircera for Anemia Associated with Chronic Kidney Disease in Pediatric Patients on Dialysis
Article Link: FDA Approves Mircera for Anemia Associated with Chronic Kidney Disease in Pediatric Patients on Dialysis On June 7, 2018, t...
U.S. FDA Approves Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta
Article Link: U.S. FDA Approves Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta HERTFORDSHIRE, England and PITTSBURGH and...
FDA Approves Olumiant (baricitinib) 2 mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis
Article Link: FDA Approves Olumiant (baricitinib) 2 mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis...
FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain
Article Link: FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain TEL AVIV, Israel, Ma...
TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause
Article Link: TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause �...
Pfizer Announces U.S. FDA Approves Xeljanz (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis
Article Link: Pfizer Announces U.S. FDA Approves Xeljanz (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis �...
UCB Announces the Approval of Cimzia (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis
Article Link: UCB Announces the Approval of Cimzia (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis Brussels, Belgium – 28th ...
FDA Approves Palynziq (pegvaliase-pqpz) for the Treatment of Adults with Phenylketonuria
Article Link: FDA Approves Palynziq (pegvaliase-pqpz) for the Treatment of Adults with Phenylketonuria May 24, 2018 – The U.S. Food...
